OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ)

CUSIP: G6S41R101

Q3 2022 13F Holders as of 30 Sep 2022

Type / Class
Equity / SHS
Total 13F shares
24,041,272
Share change
+7,677,329
Total reported value
$50,486,465
Put/Call ratio
50%
Price per share
$2.10
Number of holders
43
Value change
+$16,177,875
Number of buys
21
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP G6S41R101?
CUSIP G6S41R101 identifies RVLPQ - OSMOTICA PHARMACEUTICALS PLC - SHS in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ) as of Q3 2022

As of 30 Sep 2022, OSMOTICA PHARMACEUTICALS PLC - SHS (RVLPQ) was held by 43 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 24,041,272 shares. The largest 10 holders included Athyrium Capital Management, LP, Rovida Advisors Inc., ArrowMark Colorado Holdings LLC, MORGAN STANLEY, RENAISSANCE TECHNOLOGIES LLC, AIGH Capital Management LLC, GEODE CAPITAL MANAGEMENT, LLC, UBS OCONNOR LLC, VANGUARD GROUP INC, and BlackRock Inc.. This page lists 43 institutional shareholders reporting positions in this security for the Q3 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.